OR WAIT 15 SECS
© 2020 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2020 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
February 04, 2011
"Tops in Fraud" is a ruinous moniker for pharma-a business so dependent on basic issues of trust, integrity, quality and safety
January 01, 2011
The mediterranean nation has endeared itself to foreign businesses over the past decades, adtively positioning itself as an appealing epicenter of global pharma interest
Pharma companies will assess health reform, negotiate user fees and keep an eye on federal prosecutors in the year ahead
Incorporating the proper blend of media into your marketing initiatives will help to increase the flexibility and success of your campaigns
US Pharmacopeia has launched an ambitious moderniation campaign to ensure its standards keep pace with changes in the blobal marketplace
A surve of leading experts reveals 2011's sobering reality and the trends that smart drugmakers will follow into the next decade
Building the commercial and policy base for effective collaboration in biotech
Amgen's hub-and-spoke system combines control at home with the flexibility to respond to local needs
It's a new year. Even pharma, with its glacial timelines, has its "Out with the old, in with the new" moment. Welcome to 2011!